发明名称 NOVEL USE OF UBIQUITIN C-TERMINAL HYDROLASE-L1
摘要 The present invention relates to a composition for diagnosing cancer metastasis comprising Ubiquitin C-terminal hydrolase-L1 (UCH-L1), a use of UCH-L1 for diagnosing cancer metastasis and a method for diagnosing cancer metastasis using the same; a composition for suppressing cancer metastasis comprising an inhibitor of UCH-L1, a use of an inhibitor of UCH-L1 for suppressing cancer metastasis and a method of suppressing cancer metastasis using the same; a composition for screening a cancer metastasis inhibitor comprising UCH-L1 protein, a use of UCH-L1 protein for screening a cancer metastasis inhibitor and a method of screening cancer metastasis inhibitor using the same; a composition for screening a cancer metastasis inhibitor comprising UCH-L1 gene, a use of UCH-L1 gene for screening a cancer metastasis inhibitor, a method of screening cancer metastasis inhibitor using the same. UCH-L1 is a key molecule to modulate cell migration including the cancer invasion according to their expressing level. Thus, the monoclonal and polyclonal antibodies and the substrate of UCH-L1 can be used for diagnosis of cancer metastasis. Also, the cancer metastasis can be suppressed by inhibiting of the expression of UCH-L1 or activity of the enzyme, thus we can screen and develop an inhibitor of UCH-L1 and use it as an adjuvant drug for anticancer therapy.
申请公布号 US2009208508(A1) 申请公布日期 2009.08.20
申请号 US20060094955 申请日期 2006.11.24
申请人 SK CORPORATION 发明人 LEE KONG JOO;KIM HYUN JUNG;CHO JEONG WOO;MAENG CHEOL YOUNG;NAM YOU KYUNG;LIM SANG MI;KIM YOUNG MEE
分类号 A61K39/395;A61K31/7105;C12Q1/68 主分类号 A61K39/395
代理机构 代理人
主权项
地址